These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28954416)

  • 1. Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models.
    Lin L; Wong H
    Pharmaceutics; 2017 Sep; 9(4):. PubMed ID: 28954416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food Effects on Oral Drug Absorption: Application of Physiologically-Based Pharmacokinetic Modeling as a Predictive Tool.
    Cheng L; Wong H
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32708881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multiscale absorption and transit model for oral drug delivery: Formulation and applications during fasting conditions.
    Kannan R; Przekwas A
    Int J Numer Method Biomed Eng; 2020 Mar; 36(3):e3317. PubMed ID: 32011090
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Zhang CX; Arnold SLM
    Drug Metab Dispos; 2023 Sep; ():. PubMed ID: 37714715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food, gastrointestinal pH, and models of oral drug absorption.
    Abuhelwa AY; Williams DB; Upton RN; Foster DJ
    Eur J Pharm Biopharm; 2017 Mar; 112():234-248. PubMed ID: 27914234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of physiologically based absorption and pharmacokinetic modeling in the development process of oral modified release generic products.
    Subhani S; Kim C; Muniz P; Rodriguez M; van Os S; Suarez E; Cristofoletti R; Schmidt S; Vozmediano V
    Eur J Pharm Biopharm; 2022 Jul; 176():87-94. PubMed ID: 35598768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on computational oral absorption simulation.
    Dressman JB; Thelen K; Willmann S
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1345-64. PubMed ID: 21939427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food Effect Projections via Physiologically Based Pharmacokinetic Modeling: Predictive Case Studies.
    Tistaert C; Heimbach T; Xia B; Parrott N; Samant TS; Kesisoglou F
    J Pharm Sci; 2019 Jan; 108(1):592-602. PubMed ID: 29906472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective.
    Riedmaier AE; DeMent K; Huckle J; Bransford P; Stillhart C; Lloyd R; Alluri R; Basu S; Chen Y; Dhamankar V; Dodd S; Kulkarni P; Olivares-Morales A; Peng CC; Pepin X; Ren X; Tran T; Tistaert C; Heimbach T; Kesisoglou F; Wagner C; Parrott N
    AAPS J; 2020 Sep; 22(6):123. PubMed ID: 32981010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim®.
    Willmann S; Thelen K; Lippert J
    J Pharm Pharmacol; 2012 Jul; 64(7):997-1007. PubMed ID: 22686345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.
    Sager JE; Yu J; Ragueneau-Majlessi I; Isoherranen N
    Drug Metab Dispos; 2015 Nov; 43(11):1823-37. PubMed ID: 26296709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic prediction of food effects for Compound A tablet using PBPK model.
    Li X; Shi L; Tang X; Wang Q; Zhou L; Song W; Feng Z; Ge J; Li JK; Yang L; Wen A; Zhang Y
    Saudi J Biol Sci; 2017 Mar; 24(3):603-609. PubMed ID: 28386186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption.
    Kaur N; Narang A; Bansal AK
    Eur J Pharm Biopharm; 2018 Aug; 129():222-246. PubMed ID: 29879527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic Oral Absorption Modeling and Simulation for Formulation Development and Bioequivalence Evaluation: Report of an FDA Public Workshop.
    Zhang X; Duan J; Kesisoglou F; Novakovic J; Amidon GL; Jamei M; Lukacova V; Eissing T; Tsakalozou E; Zhao L; Lionberger R
    CPT Pharmacometrics Syst Pharmacol; 2017 Aug; 6(8):492-495. PubMed ID: 28571121
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Isoherranen N
    Drug Metab Dispos; 2024 Feb; ():. PubMed ID: 38326033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational modeling of human oral bioavailability: what will be next?
    Cabrera-Pérez MÁ; Pham-The H
    Expert Opin Drug Discov; 2018 Jun; 13(6):509-521. PubMed ID: 29663836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting human exposure of active drug after oral prodrug administration, using a joined in vitro/in silico-in vivo extrapolation and physiologically-based pharmacokinetic modeling approach.
    Malmborg J; Ploeger BA
    J Pharmacol Toxicol Methods; 2013; 67(3):203-13. PubMed ID: 23280406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBPK modeling and simulation in drug research and development.
    Zhuang X; Lu C
    Acta Pharm Sin B; 2016 Sep; 6(5):430-440. PubMed ID: 27909650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.
    Vulović A; Šušteršič T; Cvijić S; Ibrić S; Filipović N
    Eur J Pharm Sci; 2018 Feb; 113():171-184. PubMed ID: 29054499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.